MNK
$1.65
Mallinckrodt Plc
$.02
1.23%
MNK
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.38
Revenue:  N/A
Tuesday
Nov 3
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MNK reports earnings?
Beat
Meet
Miss

Where is MNK's stock price going from here?
Up
Flat
Down
Stock chart of MNK
Analysts
Summary of analysts' recommendations for MNK
Score
Grade
Pivots
Resistance
$2.12
$1.94
$1.78

$1.60

Support
$1.44
$1.26
$1.10
Tweet
Growth
Description
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonZoetisBristol-Myers SquibbUltragenyx PharmaceuticalCatalentMerck & Co.